Loading…

Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients

Introduction Circulating tumor cells (CTCs) have been proposed as a prognostic biomarker in newly-diagnosed MM (NDMM) but their low frequency questions their use in clinical practice. Lower CTC levels (cut-off

Saved in:
Bibliographic Details
Published in:Blood 2023-11, Vol.142 (Supplement 1), p.880-880
Main Authors: Kostopoulos, Ioannis V, Ntanasis-Stathopoulos, Ioannis, Rousakis, Pantelis, Eleutherakis-Papaiakovou, Evangelos, Panteli, Chrysanthi, Malandrakis, Panagiotis, Angelis, Nikolaos, Kanellias, Nikolaos, Dimitrakopoulou, Georgia, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios Athanasios, Tsitsilonis, Ourania, Terpos, Evangelos
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Circulating tumor cells (CTCs) have been proposed as a prognostic biomarker in newly-diagnosed MM (NDMM) but their low frequency questions their use in clinical practice. Lower CTC levels (cut-off
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2023-186259